June 3, 2026—Diazyme Laboratories has acquired Carolina Liquid Chemistries Corp., an FDA-registered manufacturer and reseller of chemistry systems and reagents.
“Carolina Liquid Chemistries’ cost-effective and reliable products will complement Diazyme’s proprietary enzyme and immunoassay technologies, creating synergies that will benefit laboratories of all sizes,” Dr. Chong Yuan, managing director of Diazyme Laboratories, said in a press release. “This strategic acquisition positions us to enhance our diagnostic capabilities and deliver even more comprehensive solutions to reference and clinical laboratories and improve patient outcomes.”
Headquartered in Greensboro, NC, CLC’s business will be integrated into Diazyme’s operations.